die(' Site is under construction

Dear site users

Site is under construction.

The site will be ready in less than 24 hours.

We are sorry for the inconvenience.

www.yektaweb.com

'); Reports of Biochemistry and Molecular Biology rbmb.net Basic Sciences http://rbmb.net 1 admin 2322-3480 2322-3480 10.61882/rbmb en jalali 1399 2 1 gregorian 2020 5 1 9 1 online 1 fulltext
en Evaluation of TP53 Codon 72, P21 Codon 31, and MDM2 SNP309 Polymorphisms in Iranian Patients with Acute Lymphocytic Leukemia زیست شناسی ملکولی Molecular Biology مقالات اصلی Original Article <div style="text-align: justify;"><strong><em>Background:</em></strong> The tumor suppressing protein p53 and its downstream effector p21 play important roles in cell cycle regulation. Deficiency or deactivation of these proteins as a result of gene alterations has been indicated in several cancers. Such genetic variations could be considered as susceptibility indicators in acute lymphocytic leukemia (ALL). Therefore, we investigated the associations between ALL risk and <em>TP53</em> codon 72, <em>p21</em> codon 31, and <em>MDM2</em> SNP309 polymorphisms in an Iranian population.<br> <br> <strong><em>Methods:</em></strong> Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to determine the<em> MDM2</em> T309G (rs2279744), <em>TP53</em> codon Arg72Pro (rs1042522), and <em>p21</em> Ser31Arg (rs1801270) single nucleotide polymorphisms (SNPs). This study was performed in 115 ALL patients and 115 healthy controls in Khuzestan province in southwest Iran.<br> <br> <strong><em>Results</em></strong><strong><em>:</em></strong> In the control group and ALL patients, <em>p21</em> Ser/Arg, and <em>MDM2</em> TG and GG genotypes were associated with significant 1.81-fold (95% confidence interval CI= 1.008-3.267; <em>P</em> ˂ 0.05), 11.07-fold (95% CI= 5.10-24.05; <em>P</em> < 0.0001), and 19.41-fold (95% CI= 8.56-43.99; <em>P</em> < 0.0001) increased risks for ALL, respectively. The <em>TP53</em> 72 Arg allele was significantly more prevalent in ALL patients (56.96%) than in control subjects (47.39%), and was significantly associated with ALL (OR= 1.47; 95% CI = 1.017-2.121, <em>P</em> < 0.05).<br> <br> <strong><em>Conclusions:</em></strong> The <em>MDM2</em> T309G and the <em>p21</em> Ser31Arg SNPs indicate a significantly increased risk for developing ALL in Khuzestan province.</div> Acute lymphocytic leukemia, Khuzestan, MDM2, TP53, p21. 26 32 http://rbmb.net/browse.php?a_code=A-10-401-1&slc_lang=en&sid=1 Ahmad Lotfi Garavand ahmadlg@yahoo.com 100319475328460017486 100319475328460017486 No Department of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran. Mohammad Mohammadi mohamadi47@yahoo.com 100319475328460017487 100319475328460017487 No Department of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran. Sara Mohammadzadeh s.mohamadzade9@gmail.com 100319475328460017488 100319475328460017488 Yes Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.